Download Citation
Article Source:
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
Maire V,
Baldeyron C,
Richardson M,
Tesson B,
Vincent-Salomon A,
et al.
(2013)
TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer.
PLOS ONE 8(5): e63712.
https://doi.org/10.1371/journal.pone.0063712